Immunology · Thymosin α1
Thymosin α1 and innate immune signaling in dendritic cells
September 24, 2026 · 1 min read · Models: Mouse, Cell culture
Thymosin α1 is a 28-amino-acid peptide derived from prothymosin α, first isolated from thymus extracts. Mouse and cell studies show it acts on dendritic cells through Toll-like receptor signaling, shaping T-helper responses to fungal and viral challenges.
A summary of published research for scientific reference. It is not medical advice and does not describe or endorse use in humans or animals. Findings from cell culture and animal models often do not carry over to other systems.
Origin
Allan Goldstein and colleagues isolated thymosin α1 from “thymosin fraction 5”, a calf thymus extract studied for its effects on T-cell maturation. The peptide is N-terminally acetylated and is produced by cleavage of the nuclear protein prothymosin α.
Mechanism in innate immunity
Romani and colleagues (Blood, 2004) showed that thymosin α1 activates mouse dendritic cells through TLR9 and MyD88-dependent signaling. This promoted IL-12 production and Th1 responses in mice challenged with Aspergillus fumigatus. Later studies described indoleamine 2,3-dioxygenase (IDO)-dependent tolerogenic effects, so the peptide can push responses toward immunity or regulation depending on context.
Research use
Thymosin α1 is used as a tool to study how a single endogenous peptide can tune dendritic-cell programming.
References
- Romani L, Bistoni F, Gaziano R, et al. Thymosin α1 activates dendritic cells for antifungal Th1 resistance through Toll-like receptor signaling. Blood. 2004;103(11):4232–4239.